Global Neuromyelitis Optica Drug Market by
Manufacturers, Regions, Type and Application,
Forecast to 2021
No of Pages – 115
Publishing Date - December 16, 2016
Browse detailed TOC, Tables, Figures, Charts in Global Neuromyelitis Optica Drug Market by
Manufacturers, Regions, Type and Application, Forecast to 2021 at -
http://www.360marketupdates.com/10397115
"Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system
(CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis,
which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness,
numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of
bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds
nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve
fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't
yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and
the spinal cord.
Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we
focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
"
Scope of the Report:
This report focuses on the Neuromyelitis Optica Drug in Global market, especially in North America,
Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market
based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Pfizer
FRESENIUS
TEVA
SANDOZ
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP